Skip to main content
. 2016 Mar 1;30(5):522–534. doi: 10.1101/gad.271890.115

Figure 1.

Figure 1.

PCBP4-deficient mice are prone to lung cancer and lymphoma. (A) Kaplan-Meier survival curve for wild-type (WT) (median survival time 110.4 wk ± 1.1 wk), PCBP4+/− (median survival time 102.1 wk ± 3.2 wk), and PCBP4−/− (median survival time 105.3 wk ± 9.8 wk) mice. (B) PCBP4+/− and PCBP4−/− mice are prone to lung cancer and lymphoma. (*) P < 0.05. (C) Representative images of H&E-stained normal lungs in wild-type mice and lung adenocarcinomas (ADCs) in PCBP4+/− and PCBP4−/− mice.